Patients with congenital FXI deficiency are known to have a reduced risk of venous thromboembolism and ischemic stroke and are not associated with a major risk of bleeding, which is consistent with the hypothesis that FXI has a minor role in hemostasis.10 Here, F11 is linked to venous thromboembolism.